CBRE Investment Management has acquired the Batavia life sciences building located at Leiden Bio Science Park on behalf of an institutional investor. Financial details were not disclosed.
The 12,000 sqm scheme was purchased from the developer, Provast. Construction is scheduled to start in April 2023 with completion expected at the end of 2024.
The project comprises a laboratory and office for housing Batavia Biosciences, which will produce vaccines and medicines against infectious diseases. Provast will develop the building in line with the Breeam-NL Excellent New Construction certificate for sustainability, which means it will be a completely gas-free and flexible building, among other highly sustainable specifications.
Source: https://propertyeu.info/Nieuws/CBRE-IM-picks-up-life-sciences-asset-in-Leiden/340666fc-f5e6-484d-b6fe-cf7c9fa6e55e, on 8 November 2022